Global vaccine injury advocates hold first international forum on post-COVID harm

By AI, Created 4:44 PM UTC, May 18, 2026, /AGP/ – Advocates from the U.S., U.K., Denmark and Australia gathered in a TrialSite News forum on May 12, 2026, to compare reports of alleged COVID-19 vaccine injuries and the challenges patients face in getting care, recognition and compensation. The discussion highlighted growing distrust in public health institutions and calls for better research, registries and pharmacovigilance.

Why it matters: - Advocates say people reporting serious adverse events after COVID-19 vaccination are still struggling to get diagnosis, treatment and recognition. - The forum connected patient groups across four countries that say the same problems are appearing in different health systems. - The discussion pointed to a broader risk: continued frustration over vaccine injury claims could deepen public distrust in health institutions.

What happened: - TrialSite News hosted an international public forum on May 12, 2026, focused on reported harm after COVID-19 vaccination. - Daniel O’Connor, founder of TrialSite News, moderated the event. - Panelists included Brianne Dressen of React19 in the United States, Caroline Pover of UKCVFamily in the United Kingdom, Anette Friedrichsen of Foreningen for bivirkningsramte in Denmark, and Rado Faleti of COVERSE in Australia. - The forum brought together vaccine injury advocacy groups from the U.S., U.K., Denmark and Australia.

The details: - Speakers described similar patterns across countries, despite different political systems, healthcare structures and compensation programs. - Advocates cited chronic neurological symptoms, cardiovascular complications, autoimmune disorders and severe fatigue syndromes among reported injuries. - Panelists said many patients face fragmented care, diagnostic uncertainty, financial strain from being unable to work, and social isolation. - The discussion also covered limits in national vaccine injury compensation programs. - Participants raised concerns about pharmacovigilance systems and adverse event databases. - Panelists said many affected people encounter claim denials, difficulty finding specialized care, strained family relationships and professional consequences. - The forum said some patients feel health authorities and parts of the medical establishment have shown too little compassion or recognition. - TrialSite News said the forum was meant to provide an open platform for international dialogue on a sensitive and politically charged issue. - The full discussion is available as the YouTube discussion via TrialSite News and directly on YouTube.

Between the lines: - The panel framed vaccine injury as both a medical and institutional problem, not only an individual patient issue. - Speakers argued that years of polarized pandemic messaging, censorship debates and disputes over vaccine safety communication have weakened trust. - The discussion suggested that the fight over recognition and compensation may matter as much as the underlying medical injuries for many families. - Several comments were forward-looking advocacy goals, not established outcomes.

What’s next: - Panelists called for more long-term research on rare adverse events. - The forum pushed for multidisciplinary care, better diagnostic pathways and stronger pharmacovigilance. - Participants urged international patient registries and closer clinical research collaboration. - The stated goal is a more open scientific environment that could help rebuild trust through transparency and evidence-based inquiry. - Panelists said restoring public confidence may remain difficult after years of institutional missteps and polarization around the pandemic response.